Zilver PTX Drug-Eluting Peripheral Stent Post-Approval Study
Latest Information Update: 04 Mar 2022
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral vascular disorders
- Focus Therapeutic Use
- 22 Mar 2021 Status changed from active, no longer recruiting to completed.
- 18 Dec 2020 Planned End Date changed from 1 Oct 2021 to 1 Feb 2021.
- 13 Feb 2017 Planned End Date changed from 1 Apr 2021 to 1 Oct 2021.